Since the pediatric vaccine was authorized in June for children as young as 6 months old, 4.4 percent of infants younger than 2 and 7.1 percent of toddlers between 2 and 4 years old have received at least one dose, according to national CDC data. Barely 1 percent of infants and 2 percent of toddlers are fully vaccinated.
It’s been a slow crawl to vaccinate the age group for months, and the “wait and see” approach seems to have extended past summer vacations.
Weeks after children returned to school, some infectious disease experts are surprised by the meager vaccination rates and point to unclear information about the shots.
“We haven’t done a good job explaining the long-term developmental consequences of long COVID for younger children,” Peter Hotez, MD, PhD, a pediatric and infectious disease physician at Houston’s Baylor College of Medicine, told the Post. “And future coronavirus variants are a very likely possibility.”
Experts agreed that the danger of long COVID-19 in children is still a big question — and should be a worry for parents with unvaccinated children.
“An infant or toddler won’t be able to tell you if they’ve had fatigue or constant headaches, so you wouldn’t know if something was lingering even when the obvious physical symptoms subsided,” Zachary Rubin, MD, a pediatric allergist in Illinois, told the Post.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
